Arteris (NASDAQ:AIP) COO Laurent Moll Sells 13,448 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) COO Laurent Moll sold 13,448 shares of Arteris stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $20.03, for a total transaction of $269,363.44. Following the completion of the transaction, the chief operating officer directly owned 265,530 shares in the company, valued at $5,318,565.90. The trade was a 4.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Arteris Trading Up 6.0%

Arteris stock opened at $21.52 on Friday. The stock has a market capitalization of $978.51 million, a price-to-earnings ratio of -26.24 and a beta of 1.43. The stock has a 50 day moving average of $16.42 and a two-hundred day moving average of $15.43. Arteris, Inc. has a twelve month low of $5.64 and a twelve month high of $21.57.

Arteris (NASDAQ:AIPGet Free Report) last issued its earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company had revenue of $20.14 million for the quarter, compared to analysts’ expectations of $18.55 million. Equities analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current year.

Institutional Trading of Arteris

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Raymond James Financial Inc. purchased a new stake in Arteris during the second quarter valued at about $32,000. BNP Paribas Financial Markets lifted its position in shares of Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after acquiring an additional 2,595 shares in the last quarter. Strs Ohio purchased a new stake in shares of Arteris in the 1st quarter valued at approximately $104,000. Penn Capital Management Company LLC acquired a new position in Arteris in the 3rd quarter worth approximately $109,000. Finally, Susquehanna Fundamental Investments LLC purchased a new position in Arteris during the 3rd quarter worth approximately $113,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Wall Street Zen raised Arteris from a “hold” rating to a “buy” rating in a research note on Saturday, March 21st. Northland Securities set a $24.00 target price on shares of Arteris in a research report on Friday, February 13th. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a report on Wednesday, January 21st. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $20.00 target price on shares of Arteris in a research note on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $20.17.

Check Out Our Latest Stock Analysis on AIP

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.